Effect of middle meningeal artery embolization for preventing recurrence of chronic subdural hematoma

Effect of middle meningeal artery embolization for preventing recurrence of chronic subdural hematoma - Effect of middle meningeal artery embolization for preventing recurrence of chronic subdural hematoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028869

Enrollment

Registered

2017-10-01

Start date

2017-11-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

embolization of middle meningeal artery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient under any of the following conditions 1.Patients who aged 75 or older on the acquisition date 2.rapid recurrence within a month after initial treatment 3.Patients with bilateral lesions 4.patients with antithrombotic medications

Exclusion criteria

Exclusion criteria: 1.Patients with intracranial hypotension 2.Patients with contrast agent allergy 3.Patients who are difficult to treat catheters 4.Patients with advanced jaundice 5.Patients with advanced hypoalbuminemia 6.patients with thrombocytopenia 7.bleeding tendency patient 8.Patients with massive ascites 9.Patients with high grade hepatic encephalopathy 10,High renal function defect 11.pregnant women, patients in lactation 12.Others, patients judged by physicians as inappropriate as subjects of this study

Design outcomes

Primary

Measure	Time frame
1)recurrence within 12 weeks after the treatment 2)subdural space volume a day, 1,4,12 weeks after the treatment 3)neurological deficits	—

Countries

Japan

Contacts

Public ContactIchiro Nakagawa

Nara Medical University Neurosurgery

nakagawa@naramed-u.ac.jp+80-744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026